Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated wi...
Q1 2026
May 11, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 13, 2025